Related Experiment Video

Updated: Jun 11, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

The Role of Molecular Imaging in Precision Oncology

James R Bading, Joanne E Mortimer

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |October 3, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
    10:04

    Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

    Published on: March 13, 2018

    11.9K
    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    11.8K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    11.2K
    Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
    10:04

    Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

    Published on: March 13, 2018

    11.9K
    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    11.8K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.5K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.5K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    4.9K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    4.9K

    Articles linked to this work by shared authors, journal, and citation graph.

    Association Between the Volume Transfer Constant (Ktrans) From Dynamic Contrast-Enhanced Perfusion MR and HER2 Status in Breast Cancer Brain Metastases.

    Cancer reports (Hoboken, N.J.)·2025

    Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer.

    JAMA network open·2025

    Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants.

    Cancer·2024

    UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan.

    Cancer medicine·2024

    Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.

    Blood advances·2024

    Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.

    Cancer·2024

    [68Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8+ T-Cell Dynamics in Lung Cancer Progression and Anti-PD-1 Response.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Correlation of [68Ga]Ga-RAYZ-8009 PET/CT Uptake with Immunohistochemical Glypican-3 Expression in Hepatocellular Carcinoma: A Proof-of-Target Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Comparative Evaluation of [68Ga]Ga-FAPI-04 PET Versus Conventional Imaging for Peritoneal Carcinomatosis Detection in Ovarian Carcinoma: A Multimodal Imaging Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Dual-Threshold Contouring for [68Ga]Ga-DOTATATE PET/CT and Correlation with Overall Survival in Patients with Neuroendocrine Neoplasms.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Pharmacological management of obesity: Current landscape and emerging therapies.

    Indian journal of pharmacology·2026

    Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis.

    Investigative and clinical urology·2026

    Synergistic effects of sorafenib and cilostazol in HepG2 cells.

    Journal of biosciences·2026

    MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

    Blood·2026

    Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer.

    Molecular oncology·2026

    Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2.

    Molecular oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us